Study of Treatment in Heart Disease Patients Installation in Undata Hospital, Central Sulawesi
Abstract
Introduction: Heart diseasesis a disorder of heart functionsdue to lack of bloods in the heart muscles due to narrowingsof the coronary artery. The purposesof this study was to describe t he characteristics and use of heart disease drugs based on parameters of rationality of drug use in Undata Hospital, Central Sulawesi Province including gender, age, heart drug class, complementary drug class, length of hospitalization, laboratory data, comorbidities , appropriate indications, the right drugs and the right dose.
Methods: This researchsis a non-experimental type of research conducted prospectively during February-April 2022. The sampling technique in this study was purposive sampling, namely sampling based on established criteria. All samples that met the requirements who came to the hospital were used as research samples according to the required sample size of 40 respondents and based on the available data collection time.
Results: The results of the study were 40 patients with hearts disease, the most heart disease sufferers were male with a percentage of 67.5%, in the age range of 56-65 years 32.5%, the most commonly used companion drug was Alprazolam as much as 17%, the most length of hospitalization was 4-6 days (55%), the most laboratory results were Hemoglobin/HGB examination as many as 21 patients (14.38%), the most comorbidities namely Hypertension with a percentage of 60%
Conclusion: Appropriate use of heart disease drugs based on drug rational parameters in hospitals Undata of the right indication 100%, the right drug selection 100% and the right dose 100%. Recommendedsfor further researchersscan conduct research on cardiac drug interactions.
References
Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J [Internet]. 2011 [cited 2024 Feb 6];32(23):2999–3054. Available from: https://pubmed.ncbi.nlm.nih.gov/21873419/
Ghani L, Novriani H, Penelitian P, Pengembangan D, Daya S, Kesehatan P, et al. Faktor Risiko Dominan Penyakit Jantung Koroner di Indonesia DOMINANT RISK FACTORS OF CORONARY HEART DISEASE IN INDONESIA.
. A, HANDINI MC, SIRAIT A. GAYA HIDUP SUKU BATAK YANG MENDERITA PENYAKIT JANTUNG KORONER (STUDI ETHNOGRAFI DI RSUD DR. PIRNGADI MEDAN TAHUN 2018). J Ilm KOHESI [Internet]. 2019 Jul 9 [cited 2024 Feb 6];3(3). Available from: https://kohesi.sciencemakarioz.org/index.php/JIK/article/view/76
Rana JS, Arsenault BJ, Després JP, Côté M, Talmud PJ, Ninio E, et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J [Internet]. 2011 Feb [cited 2024 Feb 6];32(3):336–44. Available from: https://pubmed.ncbi.nlm.nih.gov/19224930/
Utami I, Dewi N, Alaydrus S, Magfirah M, Musfirah M, Azizah N. Potential drug interactions in inpatients with chronic kidney disease at Undata Hospital, Palu City, Indonesia. Sci Pharm. 2023 Nov 26;2(4):37–44.
Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity?Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment: A Position Paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens [Internet]. 2013 Jan [cited 2024 Feb 6];15(1):14. Available from: /pmc/articles/PMC8108268/
Koroner J, Instalasi DI, Inap R, Prof R. EVALUASI PENGGUNAAN OBAT PADA PASIEN DENGAN PENYAKIT JANTUNG KORONER DI INSTALASI RAWAT INAP RSUP PROF. DR. R. D. KANDOU MANADO. PHARMACON [Internet]. 2017 Oct 24 [cited 2024 Feb 6];6(4):55–66. Available from: https://ejournal.unsrat.ac.id/v3/index.php/pharmacon/article/view/17718
Diah Cahyaningsih. Profil peresepan penyakit jantung koroner di rawat inap jantung periode januari - desember 2017. Akad Farm Surabaya. 2017;2017.
Pramudianto; A. MIMS Indonesia?; petunjuk Konsultasi. 2012 [cited 2024 Feb 6]; Available from: //digilib.stiksam.ac.id/index.php?p=show_detail&id=1655&keywords=
Fadiah Y. Studi Penggunaan Isosorbide Dinitrate (ISDN) Pada Pasien Jantung Koroner di RSUD Sidoarjo. Fak ILMU KESEHATAN, Univ MUHAMMADIYAH MALANG. 2017;
Fadiah Y. STUDI PENGGUNAAN (ISDN) PADA PASIEN JANTUNG KORONER (Penelitian dilakukan di RSUD Sidoarjo) ISOSORBIDE DINITRATE. 2017;
STUDI PENGGUNAAN (ISDN) PADA PASIEN JANTUNG KORONER (Penelitian dilakukan di RSUD Sidoarjo) ISOSORBIDE DINITRATE | Semantic Scholar [Internet]. [cited 2024 Feb 6]. Available from: https://www.semanticscholar.org/paper/STUDI-PENGGUNAAN-(ISDN)-PADA-PASIEN-JANTUNG-KORONER-Fadiah/0fc7427ac826f315a856244295a091edb75bd54e
Copyright (c) 2024 Niluh Puspita Dewi, Indah Kurnia Utami, Al'vira Gunawan; Muh. Thamrin Tahir, Syafika Alaydrus, Nani Astria Polontalo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Journal of Public Health and Pharmacy has CC-BY-SA or an equivalent license as the optimal license for the publication, distribution, use, and reuse of scholarly work. Authors who publish with this journal retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
